Literature DB >> 22246657

Aggregation and pH-temperature phase behavior for aggregates of an IgG2 antibody.

Erinc Sahin1, William F Weiss, Andrew M Kroetsch, Kevin R King, R Kendall Kessler, Tapan K Das, Christopher J Roberts.   

Abstract

Monomer unfolding and thermally accelerated aggregation kinetics to produce soluble oligomers or insoluble macroscopic aggregates were characterized as a function of pH for an IgG2 antibody using differential scanning calorimetry (DSC) and size-exclusion chromatography (SEC). Aggregate size was quantified via laser light scattering, and aggregate solubility via turbidity and visual inspection. Interestingly, nonnative oligomers were soluble at pH 5.5 above approximately 15°C, but converted reversibly to visible/insoluble particles at lower temperatures. Lower pH values yielded only soluble aggregates, whereas higher pH resulted in insoluble aggregates, regardless of the solution temperature. Unlike the growing body of literature that supports the three-endotherm model of IgG1 unfolding in DSC, the results here also illustrate limitations of that model for other monoclonal antibodies. Comparison of DSC with monomer loss (via SEC) from samples during thermal scanning indicates that the least conformationally stable domain is not the most aggregation prone, and that a number of the domains remain intact within the constituent monomers of the resulting aggregates. This highlights continued challenges with predicting a priori which domain(s) or thermal transition(s) is(are) most relevant for product stability with respect to aggregation.
Copyright © 2012 Wiley Periodicals, Inc.

Mesh:

Substances:

Year:  2012        PMID: 22246657     DOI: 10.1002/jps.23056

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  13 in total

Review 1.  High-throughput biophysical analysis of protein therapeutics to examine interrelationships between aggregate formation and conformational stability.

Authors:  Rajoshi Chaudhuri; Yuan Cheng; C Russell Middaugh; David B Volkin
Journal:  AAPS J       Date:  2013-10-31       Impact factor: 4.009

2.  Commentary: current perspectives on the aggregation of protein drugs.

Authors:  Elizabeth M Topp
Journal:  AAPS J       Date:  2014-02-22       Impact factor: 4.009

3.  High-throughput screening for developability during early-stage antibody discovery using self-interaction nanoparticle spectroscopy.

Authors:  Yuqi Liu; Isabelle Caffry; Jiemin Wu; Steven B Geng; Tushar Jain; Tingwan Sun; Felicia Reid; Yuan Cao; Patricia Estep; Yao Yu; Maximiliano Vásquez; Peter M Tessier; Yingda Xu
Journal:  MAbs       Date:  2013-12-06       Impact factor: 5.857

4.  Modulating non-native aggregation and electrostatic protein-protein interactions with computationally designed single-point mutations.

Authors:  C J O'Brien; M A Blanco; J A Costanzo; M Enterline; E J Fernandez; A S Robinson; C J Roberts
Journal:  Protein Eng Des Sel       Date:  2016-05-09       Impact factor: 1.650

Review 5.  Therapeutic protein aggregation: mechanisms, design, and control.

Authors:  Christopher J Roberts
Journal:  Trends Biotechnol       Date:  2014-06-04       Impact factor: 19.536

6.  Alleviating nonlinear behavior of disulfide isoforms in the reversed-phase liquid chromatography of IgG2.

Authors:  Xiang Cao; Yan He; Jacquelynn Smith; Mary J Wirth
Journal:  J Chromatogr A       Date:  2015-08-04       Impact factor: 4.759

Review 7.  Protein aggregation and its impact on product quality.

Authors:  Christopher J Roberts
Journal:  Curr Opin Biotechnol       Date:  2014-08-28       Impact factor: 9.740

8.  Probing Conformational Diversity of Fc Domains in Aggregation-Prone Monoclonal Antibodies.

Authors:  Subhabrata Majumder; Michael T Jones; Michael Kimmel; Arun Alphonse Ignatius
Journal:  Pharm Res       Date:  2018-09-25       Impact factor: 4.200

9.  Investigating monoclonal antibody aggregation using a combination of H/DX-MS and other biophysical measurements.

Authors:  Roxana E Iacob; George M Bou-Assaf; Lee Makowski; John R Engen; Steven A Berkowitz; Damian Houde
Journal:  J Pharm Sci       Date:  2013-10-17       Impact factor: 3.534

10.  Identifying protein aggregation mechanisms and quantifying aggregation rates from combined monomer depletion and continuous scattering.

Authors:  Gregory V Barnett; Michael Drenski; Vladimir Razinkov; Wayne F Reed; Christopher J Roberts
Journal:  Anal Biochem       Date:  2016-08-07       Impact factor: 3.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.